Poxviral Targeting of Interferon Regulatory Factor Activation.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
20 10 2020
Historique:
received: 06 10 2020
revised: 15 10 2020
accepted: 15 10 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 27 2 2021
Statut: epublish

Résumé

As viruses have a capacity to rapidly evolve and continually alter the coding of their protein repertoires, host cells have evolved pathways to sense viruses through the one invariable feature common to all these pathogens-their nucleic acids. These genomic and transcriptional pathogen-associated molecular patterns (PAMPs) trigger the activation of germline-encoded anti-viral pattern recognition receptors (PRRs) that can distinguish viral nucleic acids from host forms by their localization and subtle differences in their chemistry. A wide range of transmembrane and cytosolic PRRs continually probe the intracellular environment for these viral PAMPs, activating pathways leading to the activation of anti-viral gene expression. The activation of Nuclear Factor Kappa B (NFκB) and Interferon (IFN) Regulatory Factor (IRF) family transcription factors are of central importance in driving pro-inflammatory and type-I interferon (TI-IFN) gene expression required to effectively restrict spread and trigger adaptive responses leading to clearance. Poxviruses evolve complex arrays of inhibitors which target these pathways at a variety of levels. This review will focus on how poxviruses target and inhibit PRR pathways leading to the activation of IRF family transcription factors.

Identifiants

pubmed: 33092186
pii: v12101191
doi: 10.3390/v12101191
pmc: PMC7590177
pii:
doi:

Substances chimiques

Interferon Regulatory Factor-3 0
Interferon Type I 0
NF-kappa B 0
Pathogen-Associated Molecular Pattern Molecules 0
Receptors, Pattern Recognition 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cell Rep. 2018 Nov 13;25(7):1953-1965.e4
pubmed: 30428360
J Virol. 2006 Jan;80(2):578-86
pubmed: 16378960
Cell Host Microbe. 2010 Aug 19;8(2):174-85
pubmed: 20709294
Elife. 2012 Dec 18;1:e00047
pubmed: 23251783
PLoS Pathog. 2016 Dec 1;12(12):e1005955
pubmed: 27907166
J Dermatol Sci. 2002 Dec;30(3):185-94
pubmed: 12443841
Clin Cosmet Investig Dermatol. 2019 May 30;12:373-381
pubmed: 31239742
EMBO J. 1999 Dec 1;18(23):6694-704
pubmed: 10581243
PLoS Pathog. 2008 Jul 11;4(7):e1000099
pubmed: 18617992
J Leukoc Biol. 2014 Sep;96(3):427-36
pubmed: 24812060
FEBS Lett. 2008 Mar 19;582(6):997-1002
pubmed: 18307994
Cell. 2018 Aug 23;174(5):1143-1157.e17
pubmed: 30078703
PLoS Pathog. 2013;9(10):e1003649
pubmed: 24098118
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000158
pubmed: 20300203
J Biol Chem. 1998 Oct 30;273(44):29210-7
pubmed: 9786932
Science. 1999 Apr 9;284(5412):321-5
pubmed: 10195897
J Biol Chem. 2009 May 22;284(21):14136-46
pubmed: 19307177
EMBO J. 2007 Jul 11;26(13):3180-90
pubmed: 17568778
Intervirology. 2006;49(4):207-14
pubmed: 16407658
J Virol. 2009 Jun;83(11):5815-24
pubmed: 19297497
Nature. 2013 May 23;497(7450):498-502
pubmed: 23636320
PLoS Pathog. 2011 Sep;7(9):e1002247
pubmed: 21931555
J Immunol. 2010 Oct 1;185(7):4261-71
pubmed: 20802145
J Virol. 2008 Nov;82(21):10735-46
pubmed: 18715932
J Korean Med Sci. 2008 Apr;23(2):307-14
pubmed: 18437017
Nat Immunol. 2010 Jan;11(1):70-5
pubmed: 19898473
J Clin Invest. 2008 May;118(5):1776-84
pubmed: 18398511
Nature. 2000 Dec 7;408(6813):740-5
pubmed: 11130078
Protein Sci. 2007 Jan;16(1):118-24
pubmed: 17123957
PLoS Pathog. 2008 Sep 19;4(9):e1000153
pubmed: 18802464
Proc Natl Acad Sci U S A. 2018 May 15;115(20):5253-5258
pubmed: 29712834
J Virol. 2007 Aug;81(16):8707-21
pubmed: 17537851
J Immunol. 2008 Jan 1;180(1):483-91
pubmed: 18097050
EMBO J. 2000 Sep 15;19(18):4976-85
pubmed: 10990461
Immunity. 1999 Apr;10(4):421-9
pubmed: 10229185
PLoS Pathog. 2014 Apr 17;10(4):e1003989
pubmed: 24743339
J Immunol. 2012 Mar 1;188(5):2371-9
pubmed: 22301546
PLoS Pathog. 2008 Aug 15;4(8):e1000128
pubmed: 18704168
Mol Cell Biol. 2003 Nov;23(21):7780-93
pubmed: 14560022
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10162-7
pubmed: 10920188
PLoS One. 2012;7(5):e36823
pubmed: 22606294
Nat Struct Biol. 2003 Nov;10(11):922-7
pubmed: 14555995
J Virol. 2011 Oct;85(20):10814-25
pubmed: 21835795
Int Immunol. 1999 Aug;11(8):1357-62
pubmed: 10421793
Nature. 2013 Jun 20;498(7454):380-4
pubmed: 23722158
Immunity. 2013 May 23;38(5):870-80
pubmed: 23706668
J Virol. 2014 Mar;88(6):3557-67
pubmed: 24403581
Nat Struct Biol. 2003 Nov;10(11):913-21
pubmed: 14555996
Biochem Pharmacol. 2020 Apr;174:113831
pubmed: 32004549
J Gen Virol. 2013 Sep;94(Pt 9):2070-2081
pubmed: 23761407
Nat Immunol. 2012 Nov;13(11):1101-9
pubmed: 23023393
EMBO J. 2008 Aug 6;27(15):2147-57
pubmed: 18636090
Nat Rev Immunol. 2013 Jun;13(6):453-60
pubmed: 23681101
Nat Immunol. 2000 Nov;1(5):398-401
pubmed: 11062499
Immunogenetics. 2014 Jan;66(1):43-52
pubmed: 24220721
PLoS One. 2011 Apr 14;6(4):e18842
pubmed: 21533147
PLoS Pathog. 2009 Jun;5(6):e1000480
pubmed: 19543380
Sci Immunol. 2020 Jan 24;5(43):
pubmed: 31980485
J Biol Chem. 2014 Feb 7;289(6):3749-62
pubmed: 24356965
J Virol. 2003 Dec;77(24):13335-47
pubmed: 14645589
J Biol Chem. 2007 Aug 3;282(31):22816-22
pubmed: 17526488
Mol Cell Biol. 2002 Jun;22(11):3942-57
pubmed: 11997525
J Virol. 2001 Jan;75(2):850-6
pubmed: 11134298
Cell Biosci. 2019 Jan 3;9:5
pubmed: 30622699
Cytokine Growth Factor Rev. 2014 Oct;25(5):611-20
pubmed: 25081317
J Exp Med. 2004 Jun 21;199(12):1651-8
pubmed: 15210743
Exp Mol Med. 2019 Dec 11;51(12):1-13
pubmed: 31827068
EMBO J. 2006 Jul 26;25(14):3257-63
pubmed: 16858409
J Biol Chem. 2012 Jun 29;287(27):22672-82
pubmed: 22593572
J Virol. 2007 Nov;81(22):12102-10
pubmed: 17855554
J Immunol. 2014 Dec 15;193(12):6090-102
pubmed: 25385819
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):233-8
pubmed: 14679297
Mol Cell. 2014 Apr 24;54(2):289-96
pubmed: 24766893
Nature. 2019 Feb;566(7743):259-263
pubmed: 30728498
Nat Immunol. 2013 Jan;14(1):19-26
pubmed: 23238760
Science. 1994 Jun 3;264(5164):1415-21
pubmed: 8197455
J Biol Chem. 2004 Mar 12;279(11):9698-702
pubmed: 14703513
J Virol. 2014 Jun;88(12):6539-41
pubmed: 24719415
Acta Biochim Biophys Sin (Shanghai). 2015 Mar;47(3):149-55
pubmed: 25651846
PLoS Pathog. 2017 Nov 10;13(11):e1006720
pubmed: 29125880
Immunity. 2006 Sep;25(3):349-60
pubmed: 16979567
Nat Immunol. 2007 Jun;8(6):592-600
pubmed: 17468758
Viruses. 2018 Aug 04;10(8):
pubmed: 30081579
Virology. 2007 Jun 5;362(2):304-13
pubmed: 17292937
Cell Cycle. 2006 Apr;5(8):804-7
pubmed: 16582590
Science. 2003 May 16;300(5622):1148-51
pubmed: 12702806
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17093-8
pubmed: 21949249
Genes Dev. 2000 Apr 1;14(7):854-62
pubmed: 10766741
EMBO J. 1998 Nov 16;17(22):6660-9
pubmed: 9822609
Annu Rev Immunol. 2008;26:535-84
pubmed: 18303999
J Virol. 2005 May;79(10):6078-88
pubmed: 15857993
Nature. 2013 Nov 28;503(7477):530-4
pubmed: 24077100
J Exp Med. 2005 Mar 21;201(6):1007-18
pubmed: 15767367
J Mol Biol. 2009 Jan 23;385(3):843-53
pubmed: 18845156
J Biol Chem. 2002 Oct 4;277(40):37029-36
pubmed: 12133833
Annu Rev Immunol. 2001;19:623-55
pubmed: 11244049
Virology. 2011 May 10;413(2):183-93
pubmed: 21354589
J Gen Virol. 2010 Sep;91(Pt 9):2221-9
pubmed: 20519457
J Exp Med. 1999 Jun 7;189(11):1839-45
pubmed: 10359587
J Virol. 2004 Jan;78(1):353-66
pubmed: 14671117
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651
pubmed: 20457564
Mol Cell. 2009 Oct 23;36(2):315-25
pubmed: 19854139
Cell Rep. 2020 Apr 7;31(1):107492
pubmed: 32268090
Gene. 1999 Sep 3;237(1):1-14
pubmed: 10524230
Cell. 2004 Oct 29;119(3):381-92
pubmed: 15507209
J Biol Chem. 2004 Aug 27;279(35):36570-8
pubmed: 15215253
Cell Rep. 2019 May 7;27(6):1920-1933.e7
pubmed: 31067474
J Immunol. 2016 Aug 1;197(3):923-33
pubmed: 27342840
Nat Immunol. 2009 Oct;10(10):1065-72
pubmed: 19609254
J Virol. 2009 Oct;83(20):10761-9
pubmed: 19656871
Immunity. 2011 May 27;34(5):680-92
pubmed: 21616437
J Biol Chem. 1999 May 28;274(22):15751-6
pubmed: 10336476
Ann Diagn Pathol. 2014 Jun;18(3):117-24
pubmed: 24560443
Nat Commun. 2019 Nov 7;10(1):5065
pubmed: 31699977
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6442-7
pubmed: 20308556
J Virol. 2012 Jan;86(2):796-805
pubmed: 22072748
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):E265-72
pubmed: 24379396
J Virol. 2019 Jul 17;93(15):
pubmed: 31118254
Cell. 2009 Aug 7;138(3):576-91
pubmed: 19631370
Lancet Infect Dis. 2013 Oct;13(10):877-88
pubmed: 23972567
J Exp Med. 2004 Jun 21;199(12):1641-50
pubmed: 15210742
J Virol. 2006 May;80(10):5059-64
pubmed: 16641297
J Leukoc Biol. 2016 Nov;100(5):927-941
pubmed: 27343013
Nat Immunol. 2003 May;4(5):491-6
pubmed: 12692549
Mol Cell. 1997 Dec;1(1):119-29
pubmed: 9659909

Auteurs

Clara Lawler (C)

Trinity Translational Medicine Institute, St James' Campus, Trinity College Dublin, D08 W9RT Dublin, Ireland.

Gareth Brady (G)

Trinity Translational Medicine Institute, St James' Campus, Trinity College Dublin, D08 W9RT Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH